5 | AcidsIBA
11/2018
-
03/2007 |
4 | 14,15-epoxy-5,8,11-eicosatrienoic acidIBA
11/2018
-
03/2007 |
4 | Adenosine Triphosphate (ATP)IBA
01/2012
-
03/2007 |
3 | sulforaphaneIBA
02/2016
-
01/2011 |
3 | 11,12-epoxy-5,8,14-eicosatrienoic acidIBA
06/2013
-
03/2007 |
3 | Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2012
-
10/2007 |
2 | Histones (Histone)IBA
02/2016
-
07/2011 |
2 | isothiocyanic acidIBA
02/2016
-
01/2011 |
2 | Anti-Bacterial Agents (Antibiotics)IBA
01/2016
-
04/2012 |
2 | VancomycinFDA LinkGeneric
01/2016
-
04/2012 |
2 | Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
06/2013
-
02/2012 |
2 | Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2013
-
03/2007 |
2 | CytokinesIBA
04/2012
-
12/2009 |
2 | HMR 1098IBA
01/2012
-
03/2007 |
2 | NF-kappa B (NF-kB)IBA
05/2011
-
06/2010 |
2 | TeaIBA
05/2011
-
06/2010 |
2 | Lanthanoid Series Elements (Lanthanides)IBA
12/2009
-
02/2008 |
2 | CationsIBA
12/2009
-
02/2008 |
2 | GadoliniumIBA
12/2009
-
02/2008 |
2 | Peptides (Polypeptides)IBA
07/2009
-
07/2007 |
1 | Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
11/2018 |
1 | EET-BIBA
11/2018 |
1 | EnzymesIBA
11/2018 |
1 | Fibroblast Growth Factor 1 (FGF-1)IBA
11/2017 |
1 | Cardiotonic Agents (Cardiac Stimulants)IBA
11/2017 |
1 | Heparin (Liquaemin)FDA LinkGeneric
11/2017 |
1 | Heparitin Sulfate (Heparan Sulfate)IBA
11/2017 |
1 | LigandsIBA
11/2017 |
1 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2017 |
1 | Therapeutic UsesIBA
11/2017 |
1 | Telomerase (Telomerase Reverse Transcriptase)IBA
02/2016 |
1 | ChromatinIBA
02/2016 |
1 | Lysine (L-Lysine)FDA Link
02/2016 |
1 | Amino AcidsFDA Link
01/2016 |
1 | Tyrosine (L-Tyrosine)FDA Link
01/2016 |
1 | Phenylalanine (L-Phenylalanine)FDA Link
01/2016 |
1 | Tryptophan (L-Tryptophan)FDA Link
01/2016 |
1 | AndrogensIBA
01/2014 |
1 | DNA (Deoxyribonucleic Acid)IBA
01/2014 |
1 | PhytochemicalsIBA
01/2014 |
1 | MethyltransferasesIBA
01/2014 |
1 | 3,3'-diindolylmethane (diindolylmethane)IBA
01/2014 |
1 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
06/2013 |
1 | Mitochondrial Permeability Transition PoreIBA
06/2013 |
1 | Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2013 |
1 | Drinking WaterIBA
04/2012 |
1 | LeptinIBA
04/2012 |
1 | Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2012 |
1 | KATP ChannelsIBA
02/2012 |
1 | Opioid Receptors (Opioid Receptor)IBA
02/2012 |
1 | eribis peptide 94IBA
02/2012 |
1 | TubulinIBA
07/2011 |
1 | Histone Deacetylases (Histone Deacetylase)IBA
07/2011 |
1 | Hormones (Hormone)IBA
05/2011 |
1 | Cyclin D2IBA
01/2011 |
1 | Pertussis ToxinIBA
06/2010 |
1 | daidzeinIBA
01/2010 |
1 | IsoflavonesIBA
01/2010 |
1 | Anticarcinogenic AgentsIBA
01/2010 |
1 | GenisteinIBA
01/2010 |
1 | Chemotactic FactorsIBA
12/2009 |
1 | Interleukin-8 (Interleukin 8)IBA
12/2009 |
1 | salicylhydroxamic acid (SHAM)IBA
12/2009 |
1 | GasesIBA
09/2009 |
1 | Vasodilator Agents (Vasodilators)IBA
09/2009 |
1 | HydrogenIBA
09/2009 |
1 | Carbon MonoxideIBA
09/2009 |
1 | Adenosine (Adenocard)FDA LinkGeneric
03/2008 |
1 | protease-activated receptor 4IBA
03/2008 |
1 | Purinergic P1 Receptors (Adenosine Receptor)IBA
03/2008 |
1 | Thrombopoietin (c-mpl Ligand)IBA
01/2008 |
1 | Xanthine DehydrogenaseIBA
10/2007 |
1 | Xanthine OxidaseIBA
10/2007 |
1 | Nitric Oxide Synthase (NO Synthase)IBA
10/2007 |
1 | NADPH Oxidases (NAD(P)H oxidase)IBA
10/2007 |
1 | Oxidoreductases (Dehydrogenase)IBA
10/2007 |
1 | NitritesIBA
10/2007 |
1 | NitratesIBA
10/2007 |
1 | MolybdenumIBA
10/2007 |
1 | FlavoproteinsIBA
10/2007 |
1 | 2-f)quinazoline-1,3-diamine N3- cyclopropyl- 7- ((4- (1- methylethyl)phenyl)methyl)- 7H- pyrrolo(3IBA
07/2007 |
1 | WortmanninIBA
07/2007 |
1 | Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
07/2007 |
1 | ThrombinFDA Link
07/2007 |
1 | Glyburide (Glibenclamide)FDA LinkGeneric
07/2007 |
1 | mitochondrial K(ATP) channelIBA
03/2007 |